Literature DB >> 9648052

Typical hormonal profiles are accompanied by increased immunoreactivity of theca folliculi steroid 17 alpha-hydroxylase P450 in polycystic ovary syndrome.

K Katulski1, S Bornstein, M Figiel, D Wand, A Warenik-Szymankiewicz, W H Trzeciak.   

Abstract

The localisation and expression of steroid 17 alpha-hydroxylase had been studied in ovaries obtained from 40 patients in whom polycystic ovary syndrome (PCO) was diagnosed, and in 15 normal ovaries. In patients, elevated serum LH and testosterone and normal FSH, prolactin and dehydroepiandrosterone levels were recorded. Serum oestradiol concentration was slightly decreased. Immunohistochemical staining with the use of antibody directed against human cytochrome P450c17 (CYP17) revealed that in polycystic as well as in normal ovaries, steroid 17 alpha-hydroxylase is localised mainly in the thecal cells of atretic follicles and in the interstitial cells of the stroma. Greater intensity of the immunohistochemical reaction in the polycystic ovaries than in normal controls, indicates a higher concentration of CYP17 and suggests increased expression of steroid 17 alpha-hydroxylase. It is postulated that the increased expression of ovarian steroid 17 alpha-hydroxylase is an important contributory factor in the pathogenesis of PCO.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9648052     DOI: 10.1007/bf03350333

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  16 in total

1.  The polycystic ovary. I. Clinical and histologic features.

Authors:  J W GOLDZIEHER; J A GREEN
Journal:  J Clin Endocrinol Metab       Date:  1962-03       Impact factor: 5.958

2.  Immunohistochemical localization of 17 alpha-hydroxylase/C17-20 lyase and aromatase cytochrome P-450 in the human ovary during the menstrual cycle.

Authors:  T Tamura; J Kitawaki; T Yamamoto; Y Osawa; S Kominami; S Takemori; H Okada
Journal:  J Endocrinol       Date:  1992-12       Impact factor: 4.286

Review 3.  Polycystic ovary syndrome: a changing perspective.

Authors:  S Franks
Journal:  Clin Endocrinol (Oxf)       Date:  1989-07       Impact factor: 3.478

4.  PCO--from basic science to clinical practice.

Authors:  Z Blumenfeld
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1994-05-31       Impact factor: 2.435

5.  Functional studies of aromatase activity in human granulosa cells from normal and polycystic ovaries.

Authors:  G F Erickson; A J Hsueh; M E Quigley; R W Rebar; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1979-10       Impact factor: 5.958

Review 6.  Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome.

Authors:  R L Rosenfield; R B Barnes; J F Cara; A W Lucky
Journal:  Fertil Steril       Date:  1990-05       Impact factor: 7.329

7.  Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries.

Authors:  C Gilling-Smith; D S Willis; R W Beard; S Franks
Journal:  J Clin Endocrinol Metab       Date:  1994-10       Impact factor: 5.958

8.  Compartmental ovarian steroidogenesis in polycystic ovary syndrome.

Authors:  A F Haney; W S Maxson; D W Schomberg
Journal:  Obstet Gynecol       Date:  1986-11       Impact factor: 7.661

Review 9.  Regulation of expression of steroidogenic enzymes in Leydig cells.

Authors:  A H Payne; G L Youngblood
Journal:  Biol Reprod       Date:  1995-02       Impact factor: 4.285

10.  Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism.

Authors:  R L Barbieri; A Makris; R W Randall; G Daniels; R W Kistner; K J Ryan
Journal:  J Clin Endocrinol Metab       Date:  1986-05       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.